View abstracts of studies supported by our research funding.

 
Select Filters
Apply Filters
Reset Filters

Uncovering miRNA-mediated Adipose-Brain Crosstalk in Alzheimer’s Disease

Marcelo A. Mori, Ph.D.
Campinas, Brazil
2023

Association Between Longitudinal Changes in Plasma GFAP and AD Progression

Sarah Abbas, Ph.D.
Pittsburgh, PA - United States
2023

Vascular cognitive impairment in diabetes: mechanisms and intervention

Kareem Abdelsaid, Ph.D.
Charleston, SC - United States
2023

Identifying ethnic disparities in AD risk and blood biomarkers in Israel

Maison Abu Raya, M.D.
Haifa, Israel
2023

Inclusive ADRD Clinical Trials: Screening, Enrolling Latino Participants

G. Adriana Perez, Ph.D.
Philadelphia, PA - United States
2023

Identification of retromer modifiers by arrayed genome-wide perturbation

Adriano Aguzzi, M.D.
Zurich, Switzerland
2023

Pyroptosis-induced gut-brain disruption after Stroke in Alzheimer’s disease

Nadine Ahmed Kerr, Ph.D.
Miami, FL - United States
2023

Restoring Excitation-Inhibition Balance in Alzheimer’s Disease Mouse Models

Moustafa Algamal, Ph.D.
Boston, MA - United States
2023

Undiagnosed Dementia in Hospitals: Prevalence, Risk Factors, and Outcomes

Márlon Aliberti, M.D., Ph.D.
Sao Paulo, Brazil
2023

Identifying Astrocyte-Mediated Vasomotion Underlying AD Pathogenesis

Xiaoqing Alice Zhou, Ph.D.
Boston, MA - United States
2023

Uncovering the Role of SORL1 as a Key Regulator of AD Endosomal Pathology

Brooke Alisen DeRosa, Ph.D.
Miami, FL - United States
2023

Influence of the Microenvironment on the Turnover of Fluid Biomarkers

Tatiana Alvarez Giovannucci, Ph.D.
London, United Kingdom
2023

Dementia training for primary health care workers in Ethiopia

Mohammed Anbessie, M.D.
Addis Ababa, Ethiopia
2023

Interrogating Metabolic Dysregulation in Neurodegeneration Using Organoids

Madeline Andrews, Ph.D.
Tempe, AZ - United States
2023

Kv7 K+ channels, BACE1, APP, and Alzheimer's disease-related epilepsy

Fabio Antonio Borges Vigil, Ph.D.
San Antonio, TX - United States
2023

Multi-Omics Characterization of a Diverse Population in the South of Brazil

Marco Antônio De Bastiani, Ph.D.
PORTO ALEGRE, Brazil
2023

Targeted Network Attack in Assessing Brain Resilience

Georgette Argiris, Ph.D.
New York, NY - United States
2023

The Role of Astrocytic Tau Deposition onto Synaptic and Memory Dysfunction

Eleni-Kostania Argyrousi, Ph.D.
New York, NY - United States
2023

Assessing Meaningful Engagement in Advanced Dementia (MEAD)

Arlene Astell, Ph.D.
Toronto, Canada
2023

A CRISPR-Based Therapeutic for Alzheimer's disease

Brent Aulston, Ph.D.
La Jolla, CA - United States
2023

A Clinical Quality Registry for Dementia in Ethiopia (CQRD Ethiopia)

Biniyam Ayele, M.D.
Addis Ababa, Ethiopia
2023

Hypothalamic Nuclei and the Spatiotemporal Evolution of Alzheimer’s disease

Marion Baillet, Ph.D.
Liege, Belgium
2023

“Land of the Young”: Changing dementia narratives in Hollywood

Zach Bandler
Dublin, Ireland
2023

Circuit Targets to Rescue Memory Functions in Alzheimer’s Disease

Jayeeta Basu, Ph.D.
New York, NY - United States
2023

Underlying effects of ApoE variants on brain pericytes in CAA and AD

Praveen Bathini, Ph.D.
Boston, MA - United States
2023

AD Nanomedicines Targeting Vasculature Disfunction and Neuroinflammation

Giuseppe Battaglia, Ph.D.
Barcelona, Spain
2023

A Deep Learning Tool to Generalize Tau PET to Predict AD progression

Guilherme Bauer Negrini, Ph.D.
Pittsburgh, PA - United States
2023

Determining the Impact of Tau Aggregates on Neuron Loss with 2P Imaging

Rachel Bennett, Ph.D.
Boston, MA - United States
2023

Mechanisms of Complement Mediated Synaptic Removal Following Tauopathy

Matthew Benskey, Ph.D.
Grand Rapids, MI - United States
2023

Arts workshops for older Latino adults with MCI at museums

Veronica Birgit Rojas Carstensen, MFA
San Francisco, CA - United States
2023

1 2 3 4 5 6 7 8 9 10... >|